Condition

Nutritional and Metabolic Diseases

ClinicalTrials.gov condition label

Explore related research

Search across original and mapped records

Search results distinguish clinical terminology from original registry names. Shared trial participation does not imply treatment or approval.

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 28 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials28
Recruiting4
Common interventions25
Lead sponsors shown15
Advertisement

Clinical trials

28 shown
METabolic MODulation to Enhance Insulin Sensitivity and Mitochondrial Function in Type 1 Diabetes (MetMod-T1D)NCT07699380 · 2026-09-01
RECRUITING
A Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes Who Observe Ramadan FastingNCT07613307 · 2026-07-15
RECRUITING
Whole Food for Families: A Pilot RCT of a Dietary Guidelines-Based Intervention to Prevent Type 2 DiabetesNCT06482944 · 2025-10-13
RECRUITING
Influence of Glucose on Metabolism and Clinical Symptoms of Patients With Parkinson's DiseaseNCT05998772 · 2023-09-01
RECRUITING
A Study of PF-08653945 and PF-08653944 in Adults With Overweight or ObesityNCT07575932 · 2026-05-11
ACTIVE_NOT_RECRUITING
Effect of Intensive Nutrition Training, Education, and Support in Gestational Diabetes - The INTENSE-GDM TRIALNCT06127823 · 2024-01-03
COMPLETED
SMART GOALS for Youth With PrediabetesNCT06067451 · 2023-12-10
UNKNOWN
Effect of Moringa Oleifera Dehydrated Leaf Powder on the Components of Metabolic Syndrome in Mexican Adults.NCT07194577 · 2023-01-05
COMPLETED
The FibreGum Study - Changing the Course of Obesity in ChildrenNCT05540678 · 2022-11-30
TERMINATED
The Effect of Time-restricted Eating on Liver MetabolismNCT04997486 · 2021-07-20
COMPLETED
Ratio of Dietary Calcium to Magnesium on Cardiovascular RiskNCT04531267 · 2021-01-01
UNKNOWN
Integration of Health Coaching and Diabetes Education in Type 2 Diabetes Mellitus Management at Primary Health CareNCT05090488 · 2020-12-14
UNKNOWN
Efficacy and Safety of EzetimiBe/Rosuvastatin in Diabetic Dislipidemia With HypertriglyceridaemiaNCT04700436 · 2020-01-03
COMPLETED
Web-based Approach in Nutrition and DiabetesNCT04386200 · 2019-02-13
UNKNOWN
Efficacy and Safety of Nutraceuticals in Patients With Diabetes Mellitus Type II and Dyslipidemia.NCT03676309 · 2017-09-01
COMPLETED
Treatment of Overweight in General PracticeNCT03000062 · 2017-01-01
COMPLETED
Low-calorie Sweeteners and Adipose SignalingNCT03125356 · 2017-01-01
COMPLETED
Insight Into New Brown Adipose Tissue Activators.NCT04787952 · 2016-10-01
COMPLETED
Vitamin K to Slow Progression of Dyslipidemia and Diabetes Risk (Vita-K 'n' Kids Study II)NCT02959762 · 2016-10-01
UNKNOWN
A Mild Supplementation of Arabinoxylan Fiber Improves Homa Index in Overweight and Obese Subjects.NCT02847351 · 2014-07-01
UNKNOWN
Tongji-Ezhou StudyNCT03845868 · 2013-04-16
UNKNOWN
Comparison of Postprandial Inflammation in Lean and Obese SubjectsNCT01446068 · 2011-03-01
COMPLETED
A Study of Strawberries and Disease RiskNCT01199848 · 2010-09-15
COMPLETED
Nutritional Prevention of Diabetes Mellitus Type 2NCT03231839 · 2009-02-01
COMPLETED
A Study of the Safety of R256918 in Obese PatientsNCT01041677 · 2008-02-01
COMPLETED
A Study of the Safety and Effectiveness of a R256918 in Patients With Type 2 DiabetesNCT00672386 · 2007-12-01
COMPLETED
A Study of the Safety and Effectiveness of JNJ-16269110 (R256918) in Overweight and Obese PatientsNCT00622765 · 2007-11-01
COMPLETED
Southampton Women's SurveyNCT04715945 · 1998-04-06
ACTIVE_NOT_RECRUITING

Common interventions

Leading sponsors

Trial status mix

COMPLETED14
UNKNOWN7
RECRUITING4
ACTIVE_NOT_RECRUITING2
TERMINATED1

Phase mix

NA15
PHASE26
EARLY_PHASE11
PHASE31
PHASE41
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.